No description available.

Orientador: Flávio Henrique Caetano / Banca: Ana Maria Costa Leonardo / Banca: Maeli Dal Pai Silva / Banca: Maria Tercilia Vilela de Azeredo Oliveira / Banca: Carmem Silvia Fontanetti Christofoletti / Resumo: O presente estudo teve como objetivo analisar os leucócitos circulantes em microscopia de luz e eletrônica e sua distribuição sazonal, além de procurar estabelecer o período de renovação celular desses leucócitos, e principalmente de caracterizar os fagócitos mononucleares do sangue de tartaruga, e sua capacidade de fagocitose frente a material inerte. Neste trabalho utilizou-se seis tartarugas Phrynops hilarii, originárias de ilhas do estuário do rio Guaíba Porto Alegre (RS), que estavam ambientadas em nosso biotério. A coleta de sangue foi realizada em todos os períodos sazonais, por punção de vasos laterais do pescoço e coletados em tubos de ensaio heparinizados. Foram realizados esfregaços sanguíneos, corados com Leishmann e Giemsa, contando-se quinhentas células de cada animal e após a obtenção dos dados, foi aplicado o teste estatístico de Bonferroni. Para a análise autorradiográfica foi injetado 1000μCi / kg de thymidine-H A. Para microscopia eletrônica processamos a nata leucocitária obtida por meio de centrifugação do sangue, para a analise citoquímica incubamos com citidina-5'-monofosfato, betaglicerofosfato de sódio, Trimetafosfatase, para averiguar a resposta fagocitária utilizamos 0,01% de carvão coloidal.Os resultados mostram que os leucócitos de Phrynops hilarii tem descrição de leucócitos semelhantes às outras espécies, somente os basófilos e linfócitos não sofreram alterações em sua distribuição sazonal. Todos os leucócitos com exceção dos basófilos apresentaram renovação celular após sete dias. Caracterizamos monoblasto, promonócito, monócitos e macrófago no sangue circulante bem como a capacidade dos fagócitos mononucleares de fagocitar células mortas e materiais inerte. / Abstract: The aim of this study was to analyze the leukocytes in the blood using electronic and light microscopy and their seasonal distribution, also to characterize the leukocyte cells replacement and mainly to characterize the mononuclear phagocytes in the blood and their phagocytic capacity. In this study, it was used six turtles (Phrynops hilarii), caught at the Guaíba river estuary, Porto Alegre, Rio Grande do Sul, Brazil and lodged for 1 week at the Central Animal House, University of São Paulo, Ribeirão Preto, São Paulo, Brazil. Blood was obtained during the seasonal periods by puncturing the lateral vessels of the neck. The blood samples were stained by Leishmann and Giemsa, counting five hundred cells in each animal. After the obtained data, it was applied the Bonferroni test as statistical method. For the autoradiographic analysis, it was injected in the circulating blood 1000 μCi/kg of 3Hthymidine. For electronic microscopy, it was processed the leukocyte substrate by circulating blood centrifugation. For cytochemical analyses, blood smears were air dried, post-fixed in 4% formalin and submitted to the determination of the following enzyme activities: acid phosphatases (β-g1ycerophosphatase and citidine-5′-sodium monophosphatase), and trimetaphosphatase. The results showed that the leukocytes of Phrynops hilarii have the leukocytes description similar to the other species, only the basophiles and lymphocytes did not suffer alterations in their seasonal distribution. All the leukocytes, in exception of the basophiles showed cells replacement after seven days. It was characterized the monocytes and macrophages in the circulating blood as well as the phagocytes capacity. / Doutor

Made available in DSpace on 2014-06-11T19:30:56Z (GMT). No. of bitstreams: 0 Previous issue date: 2009-02-11Bitstream added on 2014-06-13T20:21:25Z : No. of bitstreams: 1 pitol_dl_dr_rcla.pdf: 2375764 bytes, checksum: 1ce362e81dd4a2ee6f04869e84243e98 (MD5) / O presente estudo teve como objetivo analisar os leucócitos circulantes em microscopia de luz e eletrônica e sua distribuição sazonal, além de procurar estabelecer o período de renovação celular desses leucócitos, e principalmente de caracterizar os fagócitos mononucleares do sangue de tartaruga, e sua capacidade de fagocitose frente a material inerte. Neste trabalho utilizou-se seis tartarugas Phrynops hilarii, originárias de ilhas do estuário do rio Guaíba Porto Alegre (RS), que estavam ambientadas em nosso biotério. A coleta de sangue foi realizada em todos os períodos sazonais, por punção de vasos laterais do pescoço e coletados em tubos de ensaio heparinizados. Foram realizados esfregaços sanguíneos, corados com Leishmann e Giemsa, contando-se quinhentas células de cada animal e após a obtenção dos dados, foi aplicado o teste estatístico de Bonferroni. Para a análise autorradiográfica foi injetado 1000μCi / kg de thymidine-H A. Para microscopia eletrônica processamos a nata leucocitária obtida por meio de centrifugação do sangue, para a analise citoquímica incubamos com citidina-5'-monofosfato, betaglicerofosfato de sódio, Trimetafosfatase, para averiguar a resposta fagocitária utilizamos 0,01% de carvão coloidal.Os resultados mostram que os leucócitos de Phrynops hilarii tem descrição de leucócitos semelhantes às outras espécies, somente os basófilos e linfócitos não sofreram alterações em sua distribuição sazonal. Todos os leucócitos com exceção dos basófilos apresentaram renovação celular após sete dias. Caracterizamos monoblasto, promonócito, monócitos e macrófago no sangue circulante bem como a capacidade dos fagócitos mononucleares de fagocitar células mortas e materiais inerte. / The aim of this study was to analyze the leukocytes in the blood using electronic and light microscopy and their seasonal distribution, also to characterize the leukocyte cells replacement and mainly to characterize the mononuclear phagocytes in the blood and their phagocytic capacity. In this study, it was used six turtles (Phrynops hilarii), caught at the Guaíba river estuary, Porto Alegre, Rio Grande do Sul, Brazil and lodged for 1 week at the Central Animal House, University of São Paulo, Ribeirão Preto, São Paulo, Brazil. Blood was obtained during the seasonal periods by puncturing the lateral vessels of the neck. The blood samples were stained by Leishmann and Giemsa, counting five hundred cells in each animal. After the obtained data, it was applied the Bonferroni test as statistical method. For the autoradiographic analysis, it was injected in the circulating blood 1000 μCi/kg of 3Hthymidine. For electronic microscopy, it was processed the leukocyte substrate by circulating blood centrifugation. For cytochemical analyses, blood smears were air dried, post-fixed in 4% formalin and submitted to the determination of the following enzyme activities: acid phosphatases (β-g1ycerophosphatase and citidine-5′-sodium monophosphatase), and trimetaphosphatase. The results showed that the leukocytes of Phrynops hilarii have the leukocytes description similar to the other species, only the basophiles and lymphocytes did not suffer alterations in their seasonal distribution. All the leukocytes, in exception of the basophiles showed cells replacement after seven days. It was characterized the monocytes and macrophages in the circulating blood as well as the phagocytes capacity.

京都大学 / 新制・課程博士 / 博士(医学) / 甲第24515号 / 医博第4957号 / 新制||医||1064(附属図書館) / 京都大学大学院医学研究科医学専攻 / (主査)教授 森信 暁雄, 教授 竹内 理, 教授 濵﨑 洋子 / 学位規則第4条第1項該当 / Doctor of Medical Science / Kyoto University / DFAM

Macrophages are leukocytes of the innate immune system that display great phenotypic plasticity to mediate diverse functions. The ontogeny of tissue resident macrophages has been debated in recent decades. It is now recognised that tissue macrophages can be replenished from embryonically-derived precursors, and/or monocyte intermediates in a tissue specific manner. Interferon Regulatory Factor 5 (IRF5) is a transcription factor that promotes a pro-inflammatory phenotype in macrophages in vitro and in vivo. Indeed, IRF5 contributes to the pathogenesis of experimental inflammatory arthritis, lupus, and obesity via recruitment and activation of effector cells. Research described here as part of this thesis, involves the profiling of the intestinal Mononuclear Phagocyte system to investigate the role of IRF5 in the development of monocyte-derived macrophages in the Colonic Lamina Propria (cLP) which are exclusively replenished by adult Ly6C^hi monocytes. Using Mixed Bone Marrow Chimaeras (MBMCs) we showed that in shared environment Wild-Type (WT) cLP macrophages dominated IRF5-deficient (Irf5^-/-) cLP macrophages in both steady state and inflammation. The development of in vitro bone marrow derived macrophages, and the reconstitution of the haematopoietic compartment in bone marrow of MBMCs were not significantly affected by IRF5 deficiency. IRF5 promoted the accumulation of WT monocytes in the cLP of MBMCs in a process possibly dependent on the CCL2/CCR2 axis. Furthermore, IRF5 expression committed Ly6C^hi monocytes to a pro-inflammatory macrophage fate in the inflamed cLP, characterised by protein expression of the cytokines IL1β, and TNFα, and the expression of Ccl4 and Ccl8 transcripts, whilst loss of IRF5 favoured accumulation of CD11b⁺ IRF4-dependent Dendritic Cells. Of significance, IRF5 expression might have prevented further differentiation of inflammatory macrophages into tissue-resident macrophages, thus supporting an inflammatory state. Irf5-/- mice were protected from Helicobacter hepaticus + αIL10R colitis. Intriguingly, protection from colitis may also be conferred by the presence of Irf5-/- haematopoietic cells, evidenced by WT:Irf5-/- MBMCs . Modulation of IRF5 activity may therefore be a viable therapeutic strategy. RNA sequencing identified that C1q, Cd81, and Ccl8 were upregulated in WT macrophages from MBMC, which may prove therapeutic targets.

Les nouveau-nés (enfants, ruminants) sont particulièrement sensibles à l’infection intestinale par le parasite Cryptosporidium parvum car leur système immunitaire est encore en cours de développement. Peu de solutions de contrôle existent à ce jour. Il n’existe pas de vaccin et seule une molécule l’Halocur™ possède une AMM pour les veaux mais l’utilisation du traitement est contraignante et il peut présenter une toxicité pour l’animal. Le développement de nouvelles alternatives immunoprophylactiques requiert de mieux comprendre les mécanismes immunitaires mis en jeux lors de l’infection. L’immunité innée joue un rôle prépondérant pour le contrôle de la phase aigüe de l’infection et nous avions montré au laboratoire que les phagocytes mononucléés CD11c+ sont des acteurs déterminant dans le processus protection. Lors de cette thèse nous avons confirmé le rôle des cellules dendritiques (DC) CD103+ en utilisant des souriceaux BatF3-/- chez qui le développement des deux sous-populations CD103+CD11b+ et CD103+CD11b- est altéré au niveau intestinal ce qui rend les animaux beaucoup plus sensibles à l’infection. / Newborns (children, ruminants) are particularly susceptible to intestinal infection by the parasite Cryptosporidium parvum because their immune system is still developing. To date, parasite control methods are limited. There is no vaccine and the only molecule which possess a marketing authorization for calves, Halocur ™, presents toxicity at 2 times the therapeutic dose. The development of new immunoprophylactic methods requires better understanding of the immune mechanisms occurring during infection. Innate immunity plays a major role in controlling the acute phase of infection and we previously demonstrated in the laboratory that intestinal mononuclear phagocytes CD11c+ are key players in the protection process. In this thesis, we confirmed the role of dendritic cells (DC) CD103+ using mice BatF3-/- in which the development of the two DC subsets CD103+CD11b+ and CD103+CD11b- is altered in the intestine making these animals more susceptible to infection. This high susceptibility can be partially mitigated by preventive administration of IL-12 to Batf3-/- neonatal mice. Batf3-/- adult mice which are only deficient for the CD103+CD11b- DC subset were transiently susceptible to infection in contrast to conventional mice that are highly resistant.

No description available.

Le CD36 est un récepteur éboueur de classe B exprimé par plusieurs types cellulaires dont les macrophages et les cellules endothéliales de la microvasculature. Le CD36 présente une haute affinité de liaison pour les ligands lipidiques tels que les lipoprotéines oxydées de basse densité (LDLox). De part sa capacité à internaliser les LDLox au niveau des macrophages et de son implication dans la formation des cellules spumeuses, le CD36 joue un rôle critique dans le développement des lésions athérosclérotiques. Nous avons testé l'hypothèse selon laquelle le EP 80317, un ligand synthétique sélectif du CD36, exerce des effets anti-athérosclérotiques chez les souris déficientes en apolipoprotéine E. Un traitement prolongé (12 semaines) avec le EP 80317 réduit fortement (de 51%) la surface des lésions athérosclérotiques par comparaison aux souris témoins. L'effet anti-athérosclérotique est associé à une diminution des taux de cholestérol plasmatique, à une réduction de l’internalisation des LDLox au niveau des macrophages et à une augmentation de l’expression des protéines impliquées dans le transport inverse du cholestérol. De plus, un traitement par le EP 80317 est également associé une diminution de l’expression aortique et plasmatique de protéines pro-inflammatoires. Nos études ont aussi montré un rôle pour le CD36 dans le recrutement des phagocytes mononucléés au niveau des lésions athérosclérotiques, tel que démontré par une réduction de l’accumulation des phagocytes mononucléés radiomarqués CD36–/– par rapport aux cellules CD36+/+. À l’échelle moléculaire, nous avons montré que les phospholipides oxydés induisent la phosphorylation de la kinase Pyk2 des podosomes des monocytes/macrophages de manière dépendante de l’expression du CD36 et de Src. Cette phosphorylation est atténuée par un traitement par le EP80317. Nos résultats appuient le rôle important du CD36 dans l’athérosclérose et suggèrent que les ligands synthétiques qui modulent la fonction du CD36 représentent potentiellement une nouvelle classe d'agents anti-athérosclérotiques. Le CD36 exprimé par les cellules endothéliales de la microvasculature est un récepteur de l’hétérodimère protéique S100A8/A9. Ces protéines s’associent à l’acide arachidonique intracellulaire (AA) des neutrophiles polymorphonucléaires (PMN) et le complexe S100A8/A9/AA peut être sécrété par les PMN activés au contact de l’endothélium. Nous avons vérifié l’hypothèse selon laquelle le CD36 exprimé par la microvasculature est impliqué dans le métabolisme transcellulaire de l’AA par la liaison du complexe S100A8/A9/AA et la réponse inflammatoire. Chez deux modèles murins d'inflammation aiguë (ischémie/reperfusion des membres inférieurs et poche d’air dorsale), nous avons observé que la réponse inflammatoire, notamment l’accumulation des PMN au niveau des sites inflammatoires, est diminuée en moyenne de 63% chez les souris CD36-/-. De même, un traitement par le EP 80317 ou par les anticorps anti-S100A8/A9 diminue chacun de 60% en moyenne l’extravasation des PMN vers les tissus inflammatoires. L’administration simultanée des deux traitements n’a aucun effet supplémentaire, et ces traitements n’exercent aucun effet chez les souris CD36-/-. Nos résultats appuient le rôle du récepteur CD36 de la microvasculature dans la régulation de la réponse inflammatoire. L’utilisation des ligands synthétiques du CD36 pourrait représenter une nouvelle avenue thérapeutique dans le traitement des réponses inflammatoires aiguës. / CD36 is a class B scavenger receptor expressed by multiple cell types such as macrophages and microvascular endothelial cells. CD36 shows a high affinity binding towards lipid-based ligands such as oxidized low-density lipoproteins (oxLDL). Macrophage CD36 has been shown to play a critical role in the development of atherosclerotic lesions by its ability to internalize oxLDL and to lead to foam cell formation. We tested the hypothesis that EP 80317, a selective CD36 ligand, exerts anti-atherosclerotic effects in apolipoprotein E-deficient (apoE–/–) mice fed on atherogenic diet. Long term treatment (12 weeks) with EP 80317 results in a striking reduction (51%) of lesion areas in EP 80317-treated apoE–/– mice. This effect was associated with a decrease in plasma cholesterol, a reduced oxLDL internalization within macrophages and an up-regulation of proteins involved in cholesterol efflux. Additionally, treatment with EP 80317 was associated with a reduced expression of vascular and plasma pro-inflammatory proteins. Our studies also showed a role of CD36 in modulating the recruitment of mononuclear phagocytes to the arterial wall, as shown by a reduced migration of radiolabeled CD36-/- macrophages into atherosclerotic lesions compared to CD36+/+ cells. At the molecular level, our studies showed that oxidized phospholipids induced the phosphorylation of the adhesion kinase Pyk2 in monocytes/macrophages, in a CD36- and Src-dependent manner. The Pyk2 phosphorylation is attenuated by treatment with EP80317. Our results strongly support the role of CD36 in atherosclerosis development and suggest that synthetic ligands featuring modulatory effect on CD36 function may represent a novel class of anti-atherosclerotic agents. CD36 expressed by microvascular endothelial cells is a receptor for the heterodimer S100A8/A9. These proteins bind intracellular arachidonic acid (AA) within polymorphonuclear neutrophils (PMN) and the complex S100A8/A9-AA may be secreted at sites of inflammation where it exerts chemotactic activities. We aimed to delineate the role of microvascular CD36, as a receptor for the S100A8/A9, in the AA transcellular metabolism and the regulation of the associated PMN trafficking to inflammatory sites. In two mouse models of acute inflammation (hind limb ischemia/reperfusion and dorsal air pouch), CD36 regulated trafficking of PMN to inflammatory sites, as shown by a mean of 63% reduction of PMN accumulation in CD36-/- mice. Treatment with EP 80317 or with S100A8/A9 antibodies reduced, each by ~ 60%, the recruitment of PMN to inflammatory sites. The combined administration of anti-S100A8/A9 and EP 80317 did not exert any additional inhibitory effect and neither treatment featured a modulatory effect in CD36-/- mice. Our results strongly support a role for microvascular CD36 in regulating PMN trafficking to inflammatory sites. Targeting CD36 might represent a novel therapeutic avenue for the treatment of acute inflammatory responses.